Savior Lifetec Corporation

Taipei Exchange 4167.TWO

Savior Lifetec Corporation Free Cash Flow for the year ending December 31, 2023: USD 12.05 M

Savior Lifetec Corporation Free Cash Flow is USD 12.05 M for the year ending December 31, 2023, a -32.52% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Savior Lifetec Corporation Free Cash Flow for the year ending December 31, 2022 was USD 17.86 M, a 287.61% change year over year.
  • Savior Lifetec Corporation Free Cash Flow for the year ending December 31, 2021 was USD -9.52 M, a -113.80% change year over year.
  • Savior Lifetec Corporation Free Cash Flow for the year ending December 31, 2020 was USD -4.45 M, a -210.79% change year over year.
  • Savior Lifetec Corporation Free Cash Flow for the year ending December 31, 2019 was USD -1.43 M, a 88.89% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Taipei Exchange: 4167.TWO

Savior Lifetec Corporation

CEO Mr. Chih-Fang Chen
IPO Date Dec. 21, 2012
Location Taiwan
Headquarters 29, Ke-Jhong Road
Employees 384
Sector Health Care
Industries
Description

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Similar companies

4147.TWO

TaiMed Biologics Inc.

USD 2.64

-2.78%

4162.TWO

PharmaEngine, Inc.

USD 2.91

-0.09%

4157.TWO

TaiGen Biopharmaceuticals Holdings Limited

USD 0.32

0.12%

4192.TWO

SynCore Biotechnology Co.,Ltd

USD 1.02

-0.84%

StockViz Staff

January 15, 2025

Any question? Send us an email